These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11794965)

  • 21. Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions.
    Hennekens CH; Sechenova O; Hollar D; Serebruany VL
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):170-6. PubMed ID: 17056829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
    Bhatt DL; Topol EJ;
    Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarction.
    Hudson M; Baron M; Rahme E; Pilote L
    J Rheumatol; 2005 Aug; 32(8):1589-93. PubMed ID: 16078339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ; Spinler SA
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Critical reading for studies on antithrombotic medications in acute coronary syndromes].
    Castaigne A
    Arch Mal Coeur Vaiss; 2002 Nov; 95 Spec No 7():49-52. PubMed ID: 12500605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of aspirin to prevent myocardial infarction and adverse outcome during follow-up - a large series of all-comers.
    Mikkelsson J; Eskola M; Nikus K; Karhunen PJ; Niemela K
    Ann Med; 2008; 40(4):296-302. PubMed ID: 18428022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin and warfarin versus aspirin monotherapy after myocardial infarction.
    Jeddy AS; Gleason BL
    Ann Pharmacother; 2003 Oct; 37(10):1502-5. PubMed ID: 14519047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin resistance and atherothrombotic disease.
    Mason PJ; Jacobs AK; Freedman JE
    J Am Coll Cardiol; 2005 Sep; 46(6):986-93. PubMed ID: 16168280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.
    Frilling B; Schiele R; Gitt AK; Zahn R; Schneider S; Glunz HG; Gieseler U; Jagodzinski E; Senges J;
    Am Heart J; 2004 Aug; 148(2):306-11. PubMed ID: 15309001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of low-molecular-weight heparin in acute coronary syndromes].
    Gharbi M; Barakett N; Lahidheb DH; Smiri Z; Fehri W; Azzouzi F; Rahal N; Mhenni H; Haouala H; Guediche M
    Tunis Med; 2002 Dec; 80(12):725-32. PubMed ID: 12664498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic therapy practices in US hospitals in an era of practice guidelines.
    Tapson VF; Hyers TM; Waldo AL; Ballard DJ; Becker RC; Caprini JA; Khetan R; Wittkowsky AK; Colgan KJ; Shillington AC;
    Arch Intern Med; 2005 Jul; 165(13):1458-64. PubMed ID: 16009860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin in primary prevention. Evidence is lacking.
    Burrill PD
    BMJ; 2010 Mar; 340():c1613. PubMed ID: 20348168
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspirin and primary prevention. BHS reaffirms its guidance.
    Sever PS;
    BMJ; 2010 Mar; 340():c1183. PubMed ID: 20197334
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin for the primary prevention of myocardial infarction.
    Relman AS
    N Engl J Med; 1988 Jan; 318(4):245-6. PubMed ID: 3275897
    [No Abstract]   [Full Text] [Related]  

  • 40. Should patients with hypertension receive antithrombotic therapy?
    Lip GY; Edmunds E; Beevers DG
    J Intern Med; 2001 Mar; 249(3):205-14. PubMed ID: 11285041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.